首页 | 本学科首页   官方微博 | 高级检索  
     


HLA class I and II in Lambert-Eaton myasthenic syndrome without associated tumor
Authors:Wirtz P W  Roep B O  Schreuder G M  van Doorn P A  van Engelen B G  Kuks J B  Twijnstra A  de Visser M  Visser L H  Wokke J H  Wintzen A R  Verschuuren J J
Affiliation:Department of Neurology, Leiden University Medical Center, The Netherlands. pwwirtz@lumc.nl
Abstract:Lambert-Eaton myasthenic syndrome (LEMS) is an autoimmune disorder, in which antibodies against voltage-gated calcium channels located at nerve terminals cause muscle weakness and autonomic dysfunction. In approximately half of the patients the autoimmune process is initiated by a tumor. In the other half of patients no tumor is found and the etiology is unknown. The aims of this study were to investigate the strength of HLA-associations with nontumor LEMS (NT-LEMS) and to study the relation of HLA-haplotypes with age at onset of LEMS and other clinical features. Therefore, typing of HLA class I and II was performed in 19 patients with NT-LEMS, who were clinically evaluated. NT-LEMS was significantly associated with alleles of both HLA-class I (i.e. HLA-B8) as well as -class II (i.e. HLA-DR3 and -DQ2). HLA-B8+ patients had significantly younger age at onset of LEMS and tended to be female. This study shows that HLA-class I haplotype is associated with a distinct phenotype in NT-LEMS.
Keywords:
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号